Societies

ESMO Guideline: Oncogene-Addicted mNSCLC – The European Society for Medical Oncology (ESMO)

Photo taken from esmo.org/guidelines

Jan 10, 2024, 11:54

ESMO Guideline: Oncogene-Addicted mNSCLC – The European Society for Medical Oncology (ESMO)

The European Society for Medical Oncology (ESMO) posted on X/Twitter:

“ESMO Guideline: Oncogene-Addicted mNSCLC. Developed due 2 advances in biomarker identification and targeted therapies; updated recommendations and treatment algorithms on new and clinically relevant biomarker identification, targeting and advanced disease management.”

View additional information.
Source: The European Society for Medical Oncology (ESMO)/X

advances in biomarker identification cancer ESMO Guideline mNSCLC OncoDaily Oncology targeted therapies The European Society for Medical Oncology (ESMO) treatment algorithms

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage